These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

347 related articles for article (PubMed ID: 9461198)

  • 1. Tissue plasminogen activator (tPA) increases neuronal damage after focal cerebral ischemia in wild-type and tPA-deficient mice.
    Wang YF; Tsirka SE; Strickland S; Stieg PE; Soriano SG; Lipton SA
    Nat Med; 1998 Feb; 4(2):228-31. PubMed ID: 9461198
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vampire bat salivary plasminogen activator (desmoteplase): a unique fibrinolytic enzyme that does not promote neurodegeneration.
    Liberatore GT; Samson A; Bladin C; Schleuning WD; Medcalf RL
    Stroke; 2003 Feb; 34(2):537-43. PubMed ID: 12574572
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vampire bat salivary plasminogen activator (desmoteplase) inhibits tissue-type plasminogen activator-induced potentiation of excitotoxic injury.
    Reddrop C; Moldrich RX; Beart PM; Farso M; Liberatore GT; Howells DW; Petersen KU; Schleuning WD; Medcalf RL
    Stroke; 2005 Jun; 36(6):1241-6. PubMed ID: 15879331
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tissue plasminogen activator (tPA) deficiency exacerbates cerebrovascular fibrin deposition and brain injury in a murine stroke model: studies in tPA-deficient mice and wild-type mice on a matched genetic background.
    Tabrizi P; Wang L; Seeds N; McComb JG; Yamada S; Griffin JH; Carmeliet P; Weiss MH; Zlokovic BV
    Arterioscler Thromb Vasc Biol; 1999 Nov; 19(11):2801-6. PubMed ID: 10559029
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aggravation of focal cerebral ischemia by tissue plasminogen activator is reversed by 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor but does not depend on endothelial NO synthase.
    Kilic E; Kilic U; Matter CM; Lüscher TF; Bassetti CL; Hermann DM
    Stroke; 2005 Feb; 36(2):332-6. PubMed ID: 15625301
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Infarct reduction in rats following intraventricular administration of either tissue plasminogen activator (tPA) or its non-protease mutant S478A-tPA.
    Yi JS; Kim YH; Koh JY
    Exp Neurol; 2004 Oct; 189(2):354-60. PubMed ID: 15380485
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tissue plasminogen activator promotes matrix metalloproteinase-9 upregulation after focal cerebral ischemia.
    Tsuji K; Aoki T; Tejima E; Arai K; Lee SR; Atochin DN; Huang PL; Wang X; Montaner J; Lo EH
    Stroke; 2005 Sep; 36(9):1954-9. PubMed ID: 16051896
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microglial-mediated PDGF-CC activation increases cerebrovascular permeability during ischemic stroke.
    Su EJ; Cao C; Fredriksson L; Nilsson I; Stefanitsch C; Stevenson TK; Zhao J; Ragsdale M; Sun YY; Yepes M; Kuan CY; Eriksson U; Strickland DK; Lawrence DA; Zhang L
    Acta Neuropathol; 2017 Oct; 134(4):585-604. PubMed ID: 28725968
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recombinant tissue plasminogen activator induces blood-brain barrier breakdown by a matrix metalloproteinase-9-independent pathway after transient focal cerebral ischemia in mouse.
    Copin JC; Bengualid DJ; Da Silva RF; Kargiotis O; Schaller K; Gasche Y
    Eur J Neurosci; 2011 Oct; 34(7):1085-92. PubMed ID: 21895804
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tissue plasminogen activator mediates microglial activation via its finger domain through annexin II.
    Siao CJ; Tsirka SE
    J Neurosci; 2002 May; 22(9):3352-8. PubMed ID: 11978811
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cell type-specific roles for tissue plasminogen activator released by neurons or microglia after excitotoxic injury.
    Siao CJ; Fernandez SR; Tsirka SE
    J Neurosci; 2003 Apr; 23(8):3234-42. PubMed ID: 12716930
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel mouse model of thromboembolic stroke.
    Chen Y; Zhu W; Zhang W; Libal N; Murphy SJ; Offner H; Alkayed NJ
    J Neurosci Methods; 2015 Dec; 256():203-11. PubMed ID: 26386284
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New thrombolytic strategy providing neuroprotection in experimental ischemic stroke: MMP10 alone or in combination with tissue-type plasminogen activator.
    Roncal C; Martinez de Lizarrondo S; Salicio A; Chevilley A; Rodriguez JA; Rosell A; Couraud PO; Weksler B; Montaner J; Vivien D; Páramo JA; Orbe J
    Cardiovasc Res; 2017 Aug; 113(10):1219-1229. PubMed ID: 28379489
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of plasminogen system components in focal cerebral ischemic infarction: a gene targeting and gene transfer study in mice.
    Nagai N; De Mol M; Lijnen HR; Carmeliet P; Collen D
    Circulation; 1999 May; 99(18):2440-4. PubMed ID: 10318667
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protease-independent action of tissue plasminogen activator in brain plasticity and neurological recovery after ischemic stroke.
    Pu H; Shi Y; Zhang L; Lu Z; Ye Q; Leak RK; Xu F; Ma S; Mu H; Wei Z; Xu N; Xia Y; Hu X; Hitchens TK; Bennett MVL; Chen J
    Proc Natl Acad Sci U S A; 2019 Apr; 116(18):9115-9124. PubMed ID: 30996120
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tissue-type plasminogen activator has paradoxical roles in focal cerebral ischemic injury by thrombotic middle cerebral artery occlusion with mild or severe photochemical damage in mice.
    Nagai N; Zhao BQ; Suzuki Y; Ihara H; Urano T; Umemura K
    J Cereb Blood Flow Metab; 2002 Jun; 22(6):648-51. PubMed ID: 12045662
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tissue plasminogen activator does not increase neuronal damage in rat models of global and focal ischemia.
    Klein GM; Li H; Sun P; Buchan AM
    Neurology; 1999 Apr; 52(7):1381-4. PubMed ID: 10227621
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-lasting neuronal loss following experimental focal cerebral ischemia is not affected by combined administration of tissue plasminogen activator and hyperbaric oxygen.
    Hobohm C; Laignel F; Kacza J; Küppers-Tiedt L; Heindl M; Schneider D; Grosche J; Härtig W; Michalski D
    Brain Res; 2011 Oct; 1417():115-26. PubMed ID: 21914554
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuroserpin, a neuroprotective factor in focal ischemic stroke.
    Cinelli P; Madani R; Tsuzuki N; Vallet P; Arras M; Zhao CN; Osterwalder T; Rülicke T; Sonderegger P
    Mol Cell Neurosci; 2001 Nov; 18(5):443-57. PubMed ID: 11922137
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of microglia reveals a non-proteolytic cytokine function for tissue plasminogen activator in the central nervous system.
    Rogove AD; Siao C; Keyt B; Strickland S; Tsirka SE
    J Cell Sci; 1999 Nov; 112 ( Pt 22)():4007-16. PubMed ID: 10547361
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.